(TSX-V: MGW, OTCQB: MGWFF)
CALGARY, June 7, 2017 /CNW/ - Maple Leaf Green World Inc.
("Maple Leaf" or the "Company") announces, further to
its press release dated May 31, 2017,
the following progress report from Cannabis Compliance Inc.
("CCI"):
"We have been contracted by Maple Leaf to assist in obtaining a
license from Health Canada (the "License") for their 80,000
square foot facility in Telkwa, British
Columbia (the "B.C. Facility") to produce and sell
cannabis products under the Access to Cannabis for Medical
Purposes Regulations ("ACMPR"). An abridged License
application is being prepared by CCI, which will expand on Maple
Leaf's product portfolio to include not only dried cannabis, but
also cannabis extracts and oil. The floor plan being developed for
the B.C. Facility will optimize cultivation, incorporate required
physical security design and risk management programs, and
implement stringent QA/GMP programs to ensure full compliance with
the ACMPR and production of high quality and safe cannabis
products. The abridged License application is expected to be
completed and submitted to Health Canada within two months. CCI
will also be responsible to communicate with Health Canada during
the License application process to address information requests
during the licensing process. We have confidence that with Maple
Leaf's total commitment, we should be able to assist Maple Leaf to
obtain the ACMPR license toward the end of 2017 as planned."
Reported by CCI.
CCI is Canada's premium cannabis consulting firm for companies
seeking to achieve licensing for cannabis. CCI has a variety of
consultants who have extensive knowledge and experience in
commercial cannabis operations in Canada for over a decade, advising on
everything from genetics sourcing, cultivation, security and
facility design, to quality assurance, regulatory licensing and
business planning. CCI's experts assist with obtaining Health
Canada approval for programs and in ensuring compliance once the
approval has been obtained. CCI, which focuses primarily in the
cannabis space, is a sister company of NHP Consulting Inc.
("NHP"). NHP, which has been in business over 10 years on
regulatory consulting for pharmaceutical, medical devices, food,
cosmetic and health products, continues to focus in these
areas.
For further information regarding Maple Leaf Green World Inc.,
please visit www.mlgreenworld.com.
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the
cannabis industry in North America
with Company currently operates 3 cannabis projects: B.C. Canada, California and Nevada U.S.A. With over 10 years of extensive
greenhouse management experience, it applies its eco-agriculture
knowledge and cultivation technology to produce contaminant-free
organic cannabis products. Maple Leaf's long-term objective is to
produce cannabis oil and export its products to approved
countries.
Cautionary Statement
This press release includes certain statements that may be
deemed "forward-looking statements" within the meaning of
applicable Canadian securities legislation. Specifically, this
press release includes, but is not limited to, forward-looking
statements with respect to the streamlining of Health Canada's
ACMPR license review process, anticipated approvals of the
Company's application for a license under the ACMPR, and
construction of the B.C. Facility. Generally, forward-looking
statements can be identified by the forward-looking terminology
such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "projects", "intends",
"anticipates", or "does not anticipate", or "believes", or
"variations of such words and phrases or state that certain
actions, events or results "may", "can", "could", "would", "might",
or "will" be taken", "occur" or "be achieved". Forward-looking
statements are subject to known and unknown risks, uncertainties,
and other factors that may cause the actual results, level of
activity, performance, or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks
related to the development and operation of the Company's projects,
risks associated with general economic conditions, adverse industry
events, marketing costs, loss of markets, future legislative and
regulatory developments involving medical cannabis, inability to
access sufficient capital from internal and external sources and/or
inability to access sufficient capital on favourable terms, the
medical cannabis industry in Canada and the jurisdictions where the Company
operates generally, income tax and regulatory matters, competition,
crop failure, currency and interest rate fluctuations, regulatory
approvals including approvals from the Health Canada of the
Company's ACMPR license application, and those factors discussed in
the sections relating to risk factors of our business filed in the
Company's required securities filings on SEDAR. Although the
Company has attempted to identify important factors that could
cause results to differ materially from those contained in
forward-looking statements, there may be other factors that cause
results to be materially different from those anticipated,
described, estimated, assessed or intended. There can be no
assurance that any forward-looking statements will prove accurate,
as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should
not place undue reliance on forward-looking statements. The Company
does not undertake to update any forward-looking statements that
are incorporated by reference herein, except in accordance with
applicable securities laws. The statements in this press release
are made as of the date of this press release. The Company
undertakes no obligation to comment on analyses, expectations, or
statements made by third parties in respect of the Company and CCI
and the description of CCI in this press release was provided by
CCI.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Maple Leaf Green World Inc.